首页|己糖激酶2在胶质瘤中的表达及与预后的关系

己糖激酶2在胶质瘤中的表达及与预后的关系

扫码查看
目的 探讨己糖激酶2(HK2)在胶质瘤中的表达及与预后的关系.方法 分别从癌症基因组图谱(TCGA)数据库和中国胶质瘤基因组图谱(CGGA)数据库下载胶质瘤HK2 mRNA表达数据集及相对应患者的临床资料进行分析,比较不同世界卫生组织(WHO)分级、性别、巢蛋白(NES)mRNA表达量、异柠檬酸脱氢酶(IDH)突变状态、染色体1p/19q共缺失情况、ATRX突变状态胶质瘤患者的HK2 mRNA表达情况.利用UCSC Xena等在线工具网站,采用Kaplan-Meier法绘制HK2 mRNA高表达组和低表达组患者的生存曲线.将HK2 mRNA表达水平与已知的生物标志物表达水平或突变情况联合分析,根据其表达水平/突变情况分别分为4个亚组,比较患者的生存情况.结果 相较于正常组织,HK2 mRNA在胶质瘤组织中高表达;相较于低级别脑胶质瘤(LGG),胶质母细胞瘤(GBM)中HK2 mRNA表达量更高.在TCGA和CGGA数据库中,WHO分级为Ⅱ级、Ⅲ级、Ⅳ级的胶质瘤患者HK2 mRNA的表达水平不同,随着胶质瘤WHO分级升高,HK2 mRNA表达增加(P﹤0.05).IDH野生型和IDH突变型、染色体1p/19q共缺失和非共缺失胶质瘤患者HK2 mRNA表达水平比较,差异均有统计学意(P﹤0.05).Kaplan-Meier生存分析结果显示,在CGGA数据库中,HK2 mRNA高表达组胶质瘤、LGG、GBM患者的生存率均低于HK2 mRNA低表达组患者,差异均有统计学意义(P﹤0.05).HK2 mRNA高表达与NES mRNA高表达、IDH1未突变、ATRX未突变提示更差预后.结论 HK2 mRNA的表达与胶质瘤的恶性程度有关,HK2 mRNA高表达患者生存率较低,HK2 mRNA可作为胶质瘤患者预后的预测指标.
Expression of hexokinase 2 in glioma and its relationship with prognosis
Objective To investigate the expression of hexokinase 2(HK2)in glioma and its relationship with prog-nosis.Method The data sets of HK2 mRNA expression in glioma and the clinical data of corresponding patients were downloaded from The Cancer Genome Atlas(TCGA)database and the Chinese Glioma Genome Atlas(CGGA)database.The expressions of HK2 mRNA in glioma patients with different World Health Organization(WHO)grades,gender,nes-tin(NES)mRNA expression,isocitrate dehydrogenase(IDH)mutation status,chromosome 1p/19q co-deletion status,and ATRX mutation status were compared.Using UCSC Xena and other online tool websites,the Kaplan-Meier method was used to draw the survival curves of the HK2 mRNA high expression group and the low expression group.The expression levels of HK2 mRNA were combined with the expression levels or mutation of known biomarkers,and the patients were divided into 4 subgroups according to their expression level/mutation,and the survival of patients were compared.Result HK2 mRNA was highly expressed in glioma tissues than normal tissues;compared with low grade glioma(LGG),the ex-pression of HK2 mRNA was higher in glioblastoma(GBM).In TCGA and CGGA databases,the expression levels of HK2 mRNA in glioma patients with WHO grade Ⅱ,Ⅲ and Ⅳ were different,with the increase of WHO grade of glioma,the expression levels of HK2 mRNA increased(P<0.05).The expression levels of HK2 mRNA in glioma patients with IDH wild type and IDH mutant type,chromosome 1p/19q co-deletion and chromosome 1p/19q non co-deletion were compared,the differences were statistically significant(P<0.05).Kaplan-Meier survival analysis showed that,in CGGA database,the survival rates of HK2 mRNA high expression group of glioma,LGG,and GBM patients were lower than those in the HK2 mRNA low expression group,and the differences were statistically significant(P<0.05).High HK2 mRNA expression,high NES mRNA expression,no IDH1 mutation and no ATRX mutation indicated poor prognosis.Con-clusion The expression of HK2 mRNA is related to the malignant degree of glioma,and the survival rate of patients with high expression of HK2 mRNA is low.HK2mRNA can be used as a predictor index of prognosis of glioma patients.

hexokinase 2gliomaprognosisbioinformatics analysis

吕晨晰、陈诗佳、任安琪、沈友协、田俊

展开 >

华中科技大学同济医学院,武汉 430030

己糖激酶2 胶质瘤 预后 生物信息学分析

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(6)
  • 19